Individuals suffering from Alzheimer’s disease (AD) use current therapy targeting acetylcholine levels in CNS synapses by applying selective AChE inhibitors: donepezil, rivastigmine and galantamine. This evidence concerns the gene ACHE and Alzheimer disease.